Compare Stocks

Date Range: 

 Tactile Systems TechnologyLeMaitre VascularOrthoPediatricsCerusSI-BONE
SymbolNASDAQ:TCMDNASDAQ:LMATNASDAQ:KIDSNASDAQ:CERSNASDAQ:SIBN
Price Information
Current Price$57.51$51.12$64.28$6.13$32.59
52 Week RangeBuyHoldBuyBuyBuy
MarketRank™
Overall Score1.21.91.31.71.5
Analysis Score1.31.21.53.52.5
Community Score2.82.92.52.92.5
Dividend Score0.01.70.00.00.0
Ownership Score0.01.71.71.71.7
Earnings & Valuation Score1.91.90.60.60.6
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$59.00$47.80$62.43$8.50$38.43
% Upside from Price Target2.59% upside-6.49% downside-2.88% downside38.66% upside17.92% upside
Trade Information
Market Cap$1.12 billion$1.05 billion$1.21 billion$1.02 billion$1.06 billion
Beta1.691.430.671.371.41
Average Volume160,655125,860196,8092,121,415291,855
Sales & Book Value
Annual Revenue$189.49 million$117.23 million$72.55 million$74.65 million$67.30 million
Price / Sales5.968.9817.4214.0315.89
Cashflow$0.84 per share$1.44 per shareN/AN/AN/A
Price / Cash68.2135.62N/AN/AN/A
Book Value$5.92 per share$7.41 per share$8.51 per share$0.41 per share$2.52 per share
Price / Book9.716.907.5514.9512.93
Profitability
Net Income$10.97 million$17.93 million$-13,730,000.00$-71,240,000.00$-38,400,000.00
EPS$0.56$0.88($0.87)($0.51)($1.55)
Trailing P/E RatioN/A54.97N/AN/AN/A
Forward P/E Ratio174.2743.32N/AN/AN/A
P/E Growth10.363.52N/AN/AN/A
Net Margins-4.57%15.41%-34.26%-73.72%-61.67%
Return on Equity (ROE)1.37%12.32%-11.57%-63.47%-45.03%
Return on Assets (ROA)0.99%8.45%-8.79%-30.82%-29.29%
Dividend
Annual PayoutN/A$0.44N/AN/AN/A
Dividend YieldN/A0.86%N/AN/AN/A
Three-Year Dividend GrowthN/A72.73%N/AN/AN/A
Payout RatioN/A50.00%N/AN/AN/A
Years of Consecutive Dividend GrowthN/A1 YearsN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.23%N/A0.36%0.39%
Current Ratio4.45%2.30%6.27%3.84%12.65%
Quick Ratio3.58%1.27%4.25%3.42%12.22%
Ownership Information
Institutional Ownership PercentageN/A84.17%71.74%82.06%65.26%
Insider Ownership Percentage5.30%16.50%33.60%6.49%15.50%
Miscellaneous
Employees707386116254295
Shares Outstanding19.63 million20.59 million19.66 million170.83 million32.81 million
Next Earnings Date8/2/2021 (Estimated)7/22/2021 (Estimated)8/4/2021 (Estimated)8/3/2021 (Estimated)8/2/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable
SourceHeadline
Canaccord Genuity Stick to Their Buy Rating for SI-Bone IncCanaccord Genuity Stick to Their Buy Rating for SI-Bone Inc
investing.com - May 4 at 11:55 PM
Morgan Stanley Stick to Their Buy Rating for SI-Bone IncMorgan Stanley Stick to Their Buy Rating for SI-Bone Inc
investing.com - May 4 at 11:55 PM
SI-BONE (NASDAQ:SIBN) PT Raised to $43.00SI-BONE (NASDAQ:SIBN) PT Raised to $43.00
americanbankingnews.com - May 4 at 6:20 PM
SI-BONE (NASDAQ:SIBN) Price Target Raised to $43.00SI-BONE (NASDAQ:SIBN) Price Target Raised to $43.00
marketbeat.com - May 4 at 4:13 PM
SI-BONE (NASDAQ:SIBN) Price Target Raised to $40.00 at Canaccord GenuitySI-BONE (NASDAQ:SIBN) Price Target Raised to $40.00 at Canaccord Genuity
americanbankingnews.com - May 4 at 3:04 PM
SI-BONE (NASDAQ:SIBN) Posts Quarterly  Earnings ResultsSI-BONE (NASDAQ:SIBN) Posts Quarterly Earnings Results
americanbankingnews.com - May 4 at 2:32 PM
SI-BONE (NASDAQ:SIBN) Price Target Raised to $43.00 at TruistSI-BONE (NASDAQ:SIBN) Price Target Raised to $43.00 at Truist
americanbankingnews.com - May 4 at 1:58 PM
SI-BONE, Inc. 2021 Q1 - Results - Earnings Call PresentationSI-BONE, Inc. 2021 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 4 at 12:51 PM
Morgan Stanley Raises SI-BONE (NASDAQ:SIBN) Price Target to $41.00Morgan Stanley Raises SI-BONE (NASDAQ:SIBN) Price Target to $41.00
americanbankingnews.com - May 4 at 12:50 PM
SI-BONE (NASDAQ:SIBN) PT Raised to $42.00 at Needham & Company LLCSI-BONE (NASDAQ:SIBN) PT Raised to $42.00 at Needham & Company LLC
americanbankingnews.com - May 4 at 11:43 AM
BRIEF-Si-Bone Reports Q1 2021 Financial Results And Reiterates 2021 Financial GuidanceBRIEF-Si-Bone Reports Q1 2021 Financial Results And Reiterates 2021 Financial Guidance
msn.com - May 4 at 12:30 AM
Recap: SI-BONE Q1 EarningsRecap: SI-BONE Q1 Earnings
benzinga.com - May 3 at 7:29 PM
Si-Bone: Q1 Earnings SnapshotSi-Bone: Q1 Earnings Snapshot
chron.com - May 3 at 7:29 PM
SI-BONE, Inc. Reports First Quarter 2021 Financial Results and Reiterates 2021 Financial GuidanceSI-BONE, Inc. Reports First Quarter 2021 Financial Results and Reiterates 2021 Financial Guidance
finance.yahoo.com - May 3 at 7:29 PM
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue EstimatesSi-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 3 at 7:29 PM
SI-BONE (NASDAQ:SIBN) Updates FY 2021 Earnings GuidanceSI-BONE (NASDAQ:SIBN) Updates FY 2021 Earnings Guidance
americanbankingnews.com - May 3 at 6:30 PM
SI-BONE (NASDAQ:SIBN) Reaches New 12-Month High at $36.52SI-BONE (NASDAQ:SIBN) Reaches New 12-Month High at $36.52
americanbankingnews.com - May 3 at 1:32 PM
SI-BONE (NASDAQ:SIBN) Price Target Raised to $38.00 at Morgan StanleySI-BONE (NASDAQ:SIBN) Price Target Raised to $38.00 at Morgan Stanley
americanbankingnews.com - April 26 at 10:58 AM
SI-BONE (NASDAQ:SIBN) Given New $38.00 Price Target at Morgan StanleySI-BONE (NASDAQ:SIBN) Given New $38.00 Price Target at Morgan Stanley
marketbeat.com - April 26 at 9:21 AM
SI-BONE to Present at the 7th Annual Truist 2021 Life Sciences Summit and the 2021 Bank of America Health Care ConferenceSI-BONE to Present at the 7th Annual Truist 2021 Life Sciences Summit and the 2021 Bank of America Health Care Conference
finance.yahoo.com - April 22 at 6:26 PM
SI-BONE (NASDAQ:SIBN) Sets New 52-Week High at $35.70SI-BONE (NASDAQ:SIBN) Sets New 52-Week High at $35.70
americanbankingnews.com - April 22 at 1:38 PM
SI-BONE, Inc. (NASDAQ:SIBN) Insider Anthony J. Recupero Sells 587 SharesSI-BONE, Inc. (NASDAQ:SIBN) Insider Anthony J. Recupero Sells 587 Shares
americanbankingnews.com - April 20 at 4:36 PM
SI-BONE, Inc. (NASDAQ:SIBN) CEO Sells $71,068.80 in StockSI-BONE, Inc. (NASDAQ:SIBN) CEO Sells $71,068.80 in Stock
americanbankingnews.com - April 20 at 4:36 PM
SI-BONE Appoints Anshul Maheshwari as Chief Financial Officer and Announces the Addition of ...SI-BONE Appoints Anshul Maheshwari as Chief Financial Officer and Announces the Addition of ...
apnews.com - April 20 at 8:46 AM
SI-BONE (NASDAQ:SIBN) PT Raised to $38.00SI-BONE (NASDAQ:SIBN) PT Raised to $38.00
americanbankingnews.com - April 19 at 1:06 PM
SI-BONE To Report First Quarter 2021 Financial Results on May 3, 2021SI-BONE To Report First Quarter 2021 Financial Results on May 3, 2021
finance.yahoo.com - April 15 at 8:22 PM
Is SIBN Stock A Buy or Sell?Is SIBN Stock A Buy or Sell?
finance.yahoo.com - April 13 at 12:46 PM
DateCompanyBrokerageAction
1/25/2021Tactile Systems TechnologyBTIG ResearchBoost Price Target
11/13/2020Tactile Systems TechnologyOppenheimerUpgrade
8/4/2020Tactile Systems TechnologyCanaccord GenuityReiterated Rating
4/6/2020Tactile Systems TechnologyPiper SandlerReiterated Rating
11/18/2019Tactile Systems TechnologyPiper Jaffray CompaniesInitiated Coverage
6/13/2019Tactile Systems TechnologyDougherty & CoInitiated Coverage
5/7/2019Tactile Systems TechnologyGuggenheimBoost Price Target
3/22/2019Tactile Systems TechnologyNorthland SecuritiesReiterated Rating
5/4/2021LeMaitre VascularRoth CapitalBoost Price Target
4/30/2021LeMaitre VascularLake Street CapitalBoost Price Target
4/30/2021LeMaitre VascularBarrington ResearchBoost Price Target
2/12/2021LeMaitre VascularKeyCorpInitiated Coverage
7/24/2020LeMaitre VascularStifel NicolausBoost Price Target
4/8/2020LeMaitre VascularSidotiLower Price Target
10/24/2019LeMaitre VascularFirst AnalysisDowngrade
5/7/2021OrthoPediatricsJMP SecuritiesBoost Price Target
4/19/2021OrthoPediatricsTruist SecuritiesBoost Price Target
8/5/2020OrthoPediatricsNeedham & Company LLCBoost Price Target
1/7/2020OrthoPediatricsSunTrust BanksInitiated Coverage
6/15/2020CerusCantor FitzgeraldInitiated Coverage
4/16/2020CerusStephensLower Price Target
8/3/2018CerusCowenSet Price Target
5/4/2021SI-BONEMorgan StanleyBoost Price Target
(Data available from 5/7/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.